Table 2. Prevalence and crude OR of association of HHV-8 seropositivity with demographic, behavioral, and clinical characteristics among female patients, Egypt*.
Characteristic |
n/N |
% |
OR |
95% CI |
p value† |
---|---|---|---|---|---|
Total | 125/495 | 25.3 | – | – | – |
Age group, y | <0.001 | ||||
15–24 | 23/148 | 15.5 | Ref | – | – |
25–34 | 21/106 | 19.8 | 1.4 | 0.7–2.7 | – |
35–44 | 31/115 | 27.0 | 2.0 | 1.1–3.6 | – |
>45 |
50/126 |
39.7 |
3.6 |
2.1–6.3 |
– |
Education | <0.001 | ||||
None | 88/307 | 28.7 | Ref | – | – |
Primary | 34/154 | 32.7 | 0.7 | 0.4–1.1 | – |
Secondary/postsecondary |
4/38 |
22.5 |
0.3 |
0.1–0.8 |
– |
Job | 0.11 | ||||
Other‡ | 2/21 | 9.5 | Ref | – | – |
Housewife |
121/470 |
25.7 |
3.3 |
0.8–14.3 |
– |
Dental treatments | 0.02 | ||||
No | 49/239 | 20.5 | Ref | – | – |
Yes |
77/260 |
29.6 |
1.6 |
1.1–2.5 |
– |
Tattoos | 0.006 | ||||
No | 93/410 | 22.7 | Ref | – | – |
Present |
33/89 |
37.1 |
2.0 |
1.2–3.3 |
– |
HCV serostatus | 0.006 | ||||
Negative | 112/470 | 23.8 | Ref | – | – |
Positive |
14/29 |
48.3 |
3.0 |
1.4–6.5 |
– |
Injections (lifetime) | 0.03 | ||||
<10 | 23/128 | 18.0 | Ref | – | – |
>10 |
103/371 |
27.8 |
1.7 |
1.1–2.9 |
– |
Schistosomiasis | 0.94 | ||||
Negative | 48/189 | 25.4 | Ref | – | – |
Positive | 76/303 | 25.1 | 1.0 | 0.6–1.5 | – |
*OR, odds ratio; HHV-8, human herpesvirus 8; CI, confidence interval; Ref, referrent; HCV, hepatitis C virus. †p value for age group and education is test for trend; otherwise, p value is test for heterogeneity. ‡Job category for women: “Other” includes women who are students, are not working, or have technical or scientific jobs.